Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
EAGLE PHARMACEUTICALS, INC. (EGRX)
|
|
Credit Analysis |
|
|
|
|
Annual | Quarterly |
|
In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| Source | Source | Source | Source | Source | Source | Source | Source |
Short-term debt | 8.3 | 7.5 | 6.3 | 35.0 | 21.8 | 23.7 | 25.6 | 8.0 |
Long-term debt | 61.9 | 68.8 | 56.2 | 26.4 | 28.0 | | | 19.5 |
Total debt | 70.2 | 76.3 | 62.5 | 61.4 | 49.9 | 23.7 | 25.6 | 27.5 |
Net debt | 54.8 | 54.4 | 7.1 | 46.0 | 7.1 | | | |
|
Debt to EBITDA | 1.1 | 1.4 | 0.7 | 0.7 | 0.8 | 0.3 | 3.9 | |
Net debt to EBITDA | 0.9 | 1.0 | 0.1 | 0.5 | 0.1 | | | |
|
EBITDA interest coverage | 10.1 | 10.6 | 23.0 | 34.5 | 36.4 | 44.4 | 4.0 | |
EBIT interest coverage | 6.7 | 6.3 | 20.0 | 31.5 | 33.8 | 42.0 | 1.7 | |
|